Your browser doesn't support javascript.
loading
Low-grade diffusely infiltrative tumour (LGDIT), SMARCB1-mutant: A clinical and histopathological distinct entity showing epigenetic similarity with ATRT-MYC.
Hasselblatt, Martin; Thomas, Christian; Federico, Aniello; Bens, Susanne; Hellström, Mats; Casar-Borota, Olivera; Kordes, Uwe; Neumann, Julia E; Dottermusch, Matthias; Rodriguez, Fausto J; Lo, Andrea C; Cheng, Sylvia; Hendson, Glenda; Hukin, Juliette; Hartmann, Christian; Koch, Arend; Capper, David; Siebert, Reiner; Paulus, Werner; Nemes, Karolina; Johann, Pascal D; Frühwald, Michael C; Kool, Marcel.
Afiliação
  • Hasselblatt M; Institute of Neuropathology, University Hospital Münster, Münster, Germany.
  • Thomas C; Institute of Neuropathology, University Hospital Münster, Münster, Germany.
  • Federico A; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.
  • Bens S; Division of Paediatric Neurooncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.
  • Hellström M; Institute of Human Genetics, Ulm University and Ulm University Medical Center, Ulm, Germany.
  • Casar-Borota O; Department of Immunology, Genetics and Pathology, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden.
  • Kordes U; Department of Immunology, Genetics and Pathology, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden.
  • Neumann JE; Department of Clinical Pathology, Uppsala University Hospital, Uppsala, Sweden.
  • Dottermusch M; Department of Pediatric Hematology and Oncology, University Medical Center, Hamburg, Germany.
  • Rodriguez FJ; Institute of Neuropathology, University Medical Center, Hamburg, Germany.
  • Lo AC; Center for Molecular Neurobiology Hamburg (ZMNH), University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Cheng S; Institute of Neuropathology, University Medical Center, Hamburg, Germany.
  • Hendson G; Center for Molecular Neurobiology Hamburg (ZMNH), University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Hukin J; Department of Pathology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Hartmann C; Radiation Oncology, British Columbia Cancer and University of British Columbia, Vancouver, Canada.
  • Koch A; Division of Hematology, Oncology and BMT, Department of Pediatrics, University of British Columbia, Vancouver, Canada.
  • Capper D; Department of Pathology, BC Women and Children's Hospital, Vancouver, Canada.
  • Siebert R; Division of Hematology, Oncology and BMT, Department of Pediatrics, University of British Columbia, Vancouver, Canada.
  • Paulus W; Department of Neuropathology, Institute of Pathology, Hannover Medical School, Hannover, Germany.
  • Nemes K; Department of Neuropathology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Johann PD; Department of Neuropathology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Frühwald MC; German Cancer Consortium (DKTK), Partner Site Berlin, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Kool M; Institute of Human Genetics, Ulm University and Ulm University Medical Center, Ulm, Germany.
Neuropathol Appl Neurobiol ; 48(4): e12797, 2022 06.
Article em En | MEDLINE | ID: mdl-35152461
Low-grade diffusely infiltrative tumour (LGDIT), SMARCB1-mutant, is a histopathological distinct low-grade lesion encountered in older children and young adults that shows epigenetic similarity with ATRT-MYC and has the potential for malignant progression.
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Limite: Adult / Child / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Limite: Adult / Child / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article